COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,002 | +4.0% | 2,103 | 0.0% | 0.00% | – |
Q2 2023 | $45,193 | +90286.0% | 2,103 | 0.0% | 0.00% | – |
Q1 2023 | $50 | -10.7% | 2,103 | -13.2% | 0.00% | – |
Q4 2022 | $56 | -99.9% | 2,423 | 0.0% | 0.00% | – |
Q3 2022 | $43,000 | +2.4% | 2,423 | +1.4% | 0.00% | – |
Q2 2022 | $42,000 | +366.7% | 2,390 | +443.2% | 0.00% | – |
Q1 2022 | $9,000 | -89.5% | 440 | -90.8% | 0.00% | -100.0% |
Q4 2021 | $86,000 | -45.2% | 4,799 | -39.7% | 0.00% | 0.0% |
Q3 2021 | $157,000 | +946.7% | 7,955 | +1183.1% | 0.00% | – |
Q2 2021 | $15,000 | 0.0% | 620 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | +25.0% | 620 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | -81.5% | 620 | -80.1% | 0.00% | -100.0% |
Q3 2020 | $65,000 | +400.0% | 3,112 | +332.2% | 0.00% | – |
Q2 2020 | $13,000 | -7.1% | 720 | -16.8% | 0.00% | – |
Q1 2020 | $14,000 | -22.2% | 865 | 0.0% | 0.00% | – |
Q4 2019 | $18,000 | -81.6% | 865 | -89.8% | 0.00% | -100.0% |
Q3 2019 | $98,000 | – | 8,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |